Unique ID issued by UMIN | UMIN000036908 |
---|---|
Receipt number | R000042060 |
Scientific Title | A dementia study by 11C-PiB, 18F-FDG PET |
Date of disclosure of the study information | 2019/05/31 |
Last modified on | 2025/02/28 16:06:26 |
A dementia study by 11C-PiB, 18F-FDG PET
A dementia study by 11C-PiB, 18F-FDG PET
A dementia study by 11C-PiB, 18F-FDG PET
A dementia study by 11C-PiB, 18F-FDG PET
Japan |
mild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, cerebrovascular dementia, frontotemporal degeneration, progressive supranuclear palsy, corticobasal degeneration, Parkinson's disease with dementia, other neurodegenerative diseases, normal pressure hydrocephalus, hypoxic encephalopathy, brain tumor, brain injury etc.
Neurology | Geriatrics | Psychiatry |
Neurosurgery |
Others
NO
The purpose is to clarify the condition of dementia by 11C-PiB, 18F-FDG PET evaluating changes in brain lesions over time in dementia and the relationship between brain lesions and cognitive functions.
Others
pathophysiology
Exploratory
Pragmatic
Not applicable
Differences in glucose metabolism , degree of accumulation of amyloid, accumulation site of amyloid by disease
Relationship between clinical features and glucose metabolism, degree and site of amyloid accumulation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
11C-PiB, 18F-FDG PET
20 | years-old | <= |
Not applicable |
Male and Female
Persons who were visited to our hospital and diagnosed with dementia or mild cognitive impairment and given an agreement on the PET study
1. Persons with other serious illnesses or unstable conditions,
2. Persons suffering from deformities / disorders of spine or hip with pain in resting position,
3. Persons judged inappropriate by doctor or the chief researcher
150
1st name | Toshihisa |
Middle name | |
Last name | Tajima |
Nagoya City Rehabilitation Agency
Bureau of Planning and Research
4678622
1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Japan
052-835-3811
ttajimat@gmail.com
1st name | Toshihisa |
Middle name | |
Last name | Tajima |
Nagoya City Rehabilitation Agency
Bureau of Planning and Research
4678622
1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Japan
052-835-3811
ttajimat@gmail.com
Nagoya City Rehabilitation Agency
none
Self funding
Nagoya City Rehabilitation Agency
1-2 Mikanyama, Yatomi-cho, Mizuho-ku, Nagoya, Japan
052-835-3811
soumubu@nagoya-rehab.or.jp
NO
名古屋市総合リハビリテーション事業団(愛知県)
2019 | Year | 05 | Month | 31 | Day |
Unpublished
161
The number of patients with negative findings on PET scan that changed the clinical diagnosis: PiB 30 (18.6%), FDG 9 (6.0%)
The number of patients with PET scan findings supportive and consistent with the clinical diagnosis was 112 (69.6%) for PiB and 60 (39.7%) for FDG.
The number of cases with atypical or abnormal findings on PET scan and no findings supporting or contradicting the clinical diagnosis was 19 (11.8%) for PiB and 82 (54.3%) for FDG.
2025 | Year | 02 | Month | 28 | Day |
72 males, 89 females, ages 41 to 91 years
Ligand and dose 11C-PiB 437 to 579 MBq/person or 18F-FDG 158 to 194 MBq/person
Number of patients tested by disease
PiB Alzheimer's disease 64 cases, Vascular dementia 8 cases, Frontotemporal dementia 14 cases, Lewy body dementia 3 cases, Mild cognitive impairment 48 cases, Others 24 cases
FDG Alzheimer's disease 61 cases, Vascular dementia 7 cases, Frontotemporal dementia 11 cases, Lewy body dementia 2 cases, Mild cognitive impairment 47 cases, Others 23 cases
Number of subjects included in the study 161 cases
Number of PiB subjects 161
Number of FDG subjects 151
none
The number of patients with negative findings on PET scan that changed the clinical diagnosis: PiB 30 (18.6%), FDG 9 (6.0%)
The number of patients with PET scan findings supportive and consistent with the clinical diagnosis was 112 (69.6%) for PiB and 60 (39.7%) for FDG.
The number of cases with atypical or abnormal findings on PET scan and no findings supporting or contradicting the clinical diagnosis was 19 (11.8%) for PiB and 82 (54.3%) for FDG.
In dementia-related diseases, PiB significantly changed the clinical diagnosis more often than FDG (p<0.001).
By disease, the clinical diagnosis was changed in 14 (21.9%) Alzheimer's disease PiB, 2 (3.3%) FDG, 4 (8.3%) mild cognitive impairment PiB, 0 (0%) FDG, and significantly more cases with PiB, whereas the PET findings were neither negative nor supportive and had little effect on the diagnosis Alzheimer's disease PiB 0 (0%) FDG 21 (34.4%), mild cognitive impairment PiB 3 (6.3%) FDG 39 (83.0%) were significantly more common with FDG (Alzheimer's disease p<0.001, mild cognitive impairment p<0.001). No significant differences were found for other dementia-related diseases. No significant differences were found for other dementia-related diseases.
Of the 64 patients diagnosed with Alzheimer's disease, 14 (21.9%) were PiB negative, and of the 48 patients diagnosed with MCI, 16 (66.7%) were PiB positive.
Among dementia patients with aphasia as the main symptom, 3 of 7 (42.9%) patients with primary progressive aphasia, 1 of 2 (50.0%) patients with semantic aphasia, and 7 of 7 (100%) patients with logopenic progressive aphasia were PiB-positive.
Completed
2019 | Year | 05 | Month | 20 | Day |
2019 | Year | 05 | Month | 29 | Day |
2019 | Year | 05 | Month | 31 | Day |
2024 | Year | 11 | Month | 13 | Day |
2024 | Year | 11 | Month | 13 | Day |
2024 | Year | 11 | Month | 13 | Day |
2024 | Year | 11 | Month | 13 | Day |
2019 | Year | 05 | Month | 31 | Day |
2025 | Year | 02 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042060